HF
RLAY icon

HRT Financial’s Relay Therapeutics RLAY Stock Holding History

HRT Financial’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,645
Closed -$259K – 4585
2025
Q4 		$259K Sell
30,645
-167,061
-84% -$1.19M ﹤0.01% 2468
2025
Q3 		$1.03M Buy
197,706
+183,589
+1,300% +$700K ﹤0.01% 1503
2025
Q2 		$48K Sell
14,117
-354,462
-96% -$1.05M ﹤0.01% 2311
2025
Q1 		$965K Buy
+368,579
New +$1.44M 0.01% 1120
2024
Q1 		– Sell
-61,039
Closed -$672K – 2968
2023
Q4 		$672K Sell
61,039
-40,993
-40% -$346K ﹤0.01% 1192
2023
Q3 		$858K Buy
102,032
+65,533
+180% +$705K 0.01% 1087
2023
Q2 		$458K Buy
+36,499
New +$454K ﹤0.01% 1402

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

HRT Financial's RLAY Position: Q1 2026 in Review

HRT Financial sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 30,645 shares — an estimated $259K sold.

HRT Financial first reported a position in RLAY in Q2 2023 and held it in 7 quarters. The position peaked at $1.03M in Q3 2025. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • HRT Financial reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 30,645 Relay Therapeutics shares in Q1 2026, an estimated $259K.
  • HRT Financial first reported a position in Relay Therapeutics in Q2 2023 and held it in 7 quarters.
  • HRT Financial's Relay Therapeutics position peaked at $1.03M in Q3 2025.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.